Sprint Bioscience AB (SPRINT) — Cash Flow Quality Index
Sprint Bioscience AB (SPRINT) has a Cash Flow Quality Index of 1.02x as of December 2025. Operating cash flow of Skr115.84 Million exceeds net income of Skr113.17 Million, indicating high earnings quality where cash backs reported profits. Explore Sprint Bioscience AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sprint Bioscience AB Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Sprint Bioscience AB across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Sprint Bioscience AB.
Annual Cash Flow Quality Index for Sprint Bioscience AB (2016–2025)
Year-by-year earnings quality comparison for Sprint Bioscience AB.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.91x | Skr83.53 Million | Skr91.74 Million | ▼ -47.6% |
| 2016 | 1.74x | Skr7.93 Million | Skr4.57 Million | — |